2005-2006
Creation of 'Chronic Pain'
Creation of the team 'Chronic Pain' :
Molecular and cellular mechanisms” team by Dr. Aziz Moqrich from the IBDM, and Dr. Stephane Gaillard, who joined this new team
2020
Sublicense exploitation agreement
2019-2020
Creation of Tafalgie Therapeutics
Creation of the company :
Completion of the Tafalgie Therapeutics founders by the arrival of Laurent Labatut and the establishment of a support team
Tafalgie Therapeutics came into being in October 2020.
This company brings together researchers and entrepreneurs with the shared aim of valorizing more than 10 years of fundamental research conducted by Dr. Aziz Moqrich and his team.
This work has been the subject of numerous publications and an international patent has been filed (by the SATT on behalf of the CNRS and AMU) concerning the use of a new protein as a potential analgesic for treating inflammatory and neuropathic pain.